AntiviralsIndirect hyperbilirubinaemia: 12 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1706卷 / 1期

关键词：

D O I：

10.1007/s40278-018-47383-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：54 / 54

相关论文

共 50 条

[21] DoxorubicinHepatobiliary adverse event and progressive hyperbilirubinaemia: 2 case reports
Reactions Weekly, 2017, 1641 (1) : 119 - 119
[22] Panobinostat/ponatinibDiarrhoea, abdominal pain and mild hyperbilirubinaemia: 2 case reports
Reactions Weekly, 2017, 1676 (1) : 235 - 235
[23] RuxolitinibAnaemia, hyperbilirubinaemia and post-transplant lymphoproliferative disorder: 3 case reports
Reactions Weekly, 2022, 1888 (1) : 312 - 312
[24] Glecaprevir/pibrentasvir/sofosbuvir/velpatasvirLack of efficacy, pruritus and hyperbilirubinaemia: 16 case reports
Reactions Weekly, 2022, 1897 (1) : 186 - 186
[25] Cytarabine/idarubicinAtypical acalculous cholecystitis, neutropenic enterocolitis and isolated hyperbilirubinaemia: 4 case reports
Reactions Weekly, 2015, 1543 (1) : 79 - 79
[26] AntioneoplasticsIntra-abdominal haemorrhage, hyperbilirubinaemia and tumour lysis syndrome: 3 case reports
Reactions Weekly, 2018, 1717 (1) : 40 - 40
[27] Anthracyclines/busulfan/posaconazoleTreatment failure following drug interaction and hyperbilirubinaemia: 2 case reports
Reactions Weekly, 2020, 1800 (1) : 39 - 39
[28] HydroxychloroquineRetinopathy: 12 case reports
Reactions Weekly, 2019, 1775 (1) : 242 - 242
[29] DipyroneAgranulocytosis: 12 case reports
Reactions Weekly, 2021, 1845 (1) : 162 - 162
[30] DiclofenacHypersensitivity: 12 case reports
Reactions Weekly, 2000, 803 (1) : 7 - 7

← 1 2 3 4 5 →